Rapid eye movement sleep alterations in myasthenia gravis

O. Papazian

Research output: Contribution to journalArticle

60 Citations (Scopus)

Abstract

The nocturnal sleep patterns of 10 patients with myasthenia gravis and five controls were recorded in the conventional manner for 7 hours on two consecutive nights. One patient was retested 4 weeks after institution of prednisone therapy. All the myasthenics had a significant disturbance in rapid eye movement (REM) sleep cycles. In the patient who was retested after clinically successful prednisone therapy, the REM sleep pattern had become normal. Since acetylcholine is the putative brain stem transmitter substance involved in the maintenance of REM sleep, the findings suggest a disturbed central mechanism of acetylcholine in myasthenia gravis.

Original languageEnglish
Pages (from-to)311-316
Number of pages6
JournalNeurology
Volume26
Issue number4
StatePublished - Dec 1 1976

Fingerprint

Myasthenia Gravis
REM Sleep
Sleep
Prednisone
Acetylcholine
Muscle Weakness
Brain Stem
Maintenance
Therapeutics

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Rapid eye movement sleep alterations in myasthenia gravis. / Papazian, O.

In: Neurology, Vol. 26, No. 4, 01.12.1976, p. 311-316.

Research output: Contribution to journalArticle

Papazian, O 1976, 'Rapid eye movement sleep alterations in myasthenia gravis', Neurology, vol. 26, no. 4, pp. 311-316.
Papazian, O. / Rapid eye movement sleep alterations in myasthenia gravis. In: Neurology. 1976 ; Vol. 26, No. 4. pp. 311-316.
@article{fbc55620b7334f96b61527047a58e41e,
title = "Rapid eye movement sleep alterations in myasthenia gravis",
abstract = "The nocturnal sleep patterns of 10 patients with myasthenia gravis and five controls were recorded in the conventional manner for 7 hours on two consecutive nights. One patient was retested 4 weeks after institution of prednisone therapy. All the myasthenics had a significant disturbance in rapid eye movement (REM) sleep cycles. In the patient who was retested after clinically successful prednisone therapy, the REM sleep pattern had become normal. Since acetylcholine is the putative brain stem transmitter substance involved in the maintenance of REM sleep, the findings suggest a disturbed central mechanism of acetylcholine in myasthenia gravis.",
author = "O. Papazian",
year = "1976",
month = "12",
day = "1",
language = "English",
volume = "26",
pages = "311--316",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Rapid eye movement sleep alterations in myasthenia gravis

AU - Papazian, O.

PY - 1976/12/1

Y1 - 1976/12/1

N2 - The nocturnal sleep patterns of 10 patients with myasthenia gravis and five controls were recorded in the conventional manner for 7 hours on two consecutive nights. One patient was retested 4 weeks after institution of prednisone therapy. All the myasthenics had a significant disturbance in rapid eye movement (REM) sleep cycles. In the patient who was retested after clinically successful prednisone therapy, the REM sleep pattern had become normal. Since acetylcholine is the putative brain stem transmitter substance involved in the maintenance of REM sleep, the findings suggest a disturbed central mechanism of acetylcholine in myasthenia gravis.

AB - The nocturnal sleep patterns of 10 patients with myasthenia gravis and five controls were recorded in the conventional manner for 7 hours on two consecutive nights. One patient was retested 4 weeks after institution of prednisone therapy. All the myasthenics had a significant disturbance in rapid eye movement (REM) sleep cycles. In the patient who was retested after clinically successful prednisone therapy, the REM sleep pattern had become normal. Since acetylcholine is the putative brain stem transmitter substance involved in the maintenance of REM sleep, the findings suggest a disturbed central mechanism of acetylcholine in myasthenia gravis.

UR - http://www.scopus.com/inward/record.url?scp=0017272250&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017272250&partnerID=8YFLogxK

M3 - Article

C2 - 177902

AN - SCOPUS:0017272250

VL - 26

SP - 311

EP - 316

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 4

ER -